BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 15173059)

  • 1. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U; Libby P
    Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward immunomodulatory and anti-inflammatory properties of statins.
    Arnaud C; Braunersreuther V; Mach F
    Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiinflammatory and immunomodulatory properties of statins.
    Shovman O; Levy Y; Gilburd B; Shoenfeld Y
    Immunol Res; 2002; 25(3):271-85. PubMed ID: 12018465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pleiotropic effects of statins].
    Wolfovitz E
    Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP; Deanfield JE
    Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential roles for statins in critically ill patients.
    Weant KA; Cook AM
    Pharmacotherapy; 2007 Sep; 27(9):1279-96. PubMed ID: 17723082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
    Katz MS
    Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcirculation as a target for the anti-inflammatory properties of statins.
    Scalia R; Stalker TJ
    Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HMG-CoA reductase inhibition on brain pathology.
    Zipp F; Waiczies S; Aktas O; Neuhaus O; Hemmer B; Schraven B; Nitsch R; Hartung HP
    Trends Pharmacol Sci; 2007 Jul; 28(7):342-9. PubMed ID: 17573124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and plaque stability.
    Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R
    J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
    Arnaud C; Mach F
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and autoimmune diseases.
    Gurevich VS; Shovman O; Slutzky L; Meroni PL; Shoenfeld Y
    Autoimmun Rev; 2005 Mar; 4(3):123-9. PubMed ID: 15823497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway.
    Paumelle R; Blanquart C; Briand O; Barbier O; Duhem C; Woerly G; Percevault F; Fruchart JC; Dombrowicz D; Glineur C; Staels B
    Circ Res; 2006 Feb; 98(3):361-9. PubMed ID: 16397146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of statins beyond lipid lowering: potential for clinical benefits.
    Almuti K; Rimawi R; Spevack D; Ostfeld RJ
    Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases.
    Chow SC
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):243-51. PubMed ID: 19578811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects and cholesterol-lowering therapy.
    Shaw SM; Fildes JE; Yonan N; Williams SG
    Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.